Case study: Reduce plate counts with rapid microbial monitoring
Find out how a pharma company maintained product quality and reduced plate counts by 25 percent using a rapid microbial monitoring analyser – the 7000RMS.
To remain competitive in the global marketplace, biotech and pharmaceutical companies focus on optimising costs while improving efficiency and mitigating risk. This case study explains how a pharmaceutical company in China addresses this challenge through real-time microbial detection used in parallel with plate counts to reduce bioburden monitoring costs while also implementing a more comprehensive process control strategy.
Related content from this organisation
Analytical techniques, Biologics, Biopharmaceuticals, Bioprocessing, Biosimilars, Data integrity, Environmental Monitoring, Good Manufacturing Practice (GMP), Manufacturing, Medical Devices, Microbiology, QA/QC, Regulation & Legislation, Research & Development (R&D)